Alterity Therapeutics (ATHE) Enterprise Value (2009 - 2025)
Alterity Therapeutics (ATHE) recorded quarterly Enterprise Value of -$32.3 million in Q4 2025, down 51.93% quarter-over-quarter from -$21.3 million in Q2 2025, and down 988.88% on a YoY basis from $3.6 million in Q4 2024.
Alterity Therapeutics (ATHE) Enterprise Value (2009 - 2025) Analysis & Trends
Alterity Therapeutics' Enterprise Value history runs 16 years deep, the most recent figure standing at -$32.3 million for Q4 2025.
- In Q4 2025, Enterprise Value fell 988.88% year-over-year to -$32.3 million; the TTM figure through Dec 2025 stood at -$32.3 million (down 988.88% YoY), while the FY2025 annual figure was -$21.3 million, down 104.02% from the prior year.
- Enterprise Value was -$32.3 million for Q4 2025 at Alterity Therapeutics, down from -$21.3 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$3.0 million in Q4 2024 to a low of -$32.3 million in Q4 2025.
- Historically, Enterprise Value has averaged -$17.4 million across 5 years, with a median of -$19.0 million in 2025.
- The sharpest annual moves came in 2024 and 2025: Enterprise Value surged 63.01% in 2024, then slumped 988.88% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$27.0 million in 2021, then jumped by 38.24% to -$16.6 million in 2022, then soared by 51.82% to -$8.0 million in 2023, then jumped by 63.01% to -$3.0 million in 2024, then plunged by 988.88% to -$32.3 million in 2025.
- The last three Enterprise Value figures came in at -$32.3 million (Q4 2025), -$21.3 million (Q2 2025), and -$3.0 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -2.77 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | -18.44 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -584.73 Mn |
| 10 | Regeneron Pharmaceuticals | 66.09 Bn | 57.33 Bn | 3.31 Bn | -8.75 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -32.30 Mn |
| Jun 30, 2025 | -21.26 Mn |
| Dec 31, 2024 | -2.97 Mn |
| Jun 30, 2024 | -8.36 Mn |
| Dec 31, 2023 | -8.02 Mn |
| Jun 30, 2023 | -10.57 Mn |
| Dec 31, 2022 | -16.65 Mn |
| Jun 30, 2022 | -24.94 Mn |
| Dec 31, 2021 | -26.96 Mn |
| Jun 30, 2021 | -21.65 Mn |
| Dec 31, 2020 | -25.61 Mn |
| Jun 30, 2020 | -6.03 Mn |
| Dec 31, 2019 | -8.32 Mn |
| Jun 30, 2019 | -10.09 Mn |
| Dec 31, 2018 | -6.01 Mn |
| Jun 30, 2018 | -11.53 Mn |
| Dec 31, 2017 | -15.31 Mn |
| Jun 30, 2017 | -16.44 Mn |
| Dec 31, 2016 | -21.26 Mn |
| Jun 30, 2016 | -21.35 Mn |